Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Sep;22(2):17-31.
doi: 10.1007/BF02913308.

Tumour markers: An overview

T Malati  1
Affiliations

Tumour markers: An overview

T Malati. Indian J Clin Biochem. 2007 Sep.

Abstract

Tumor Markers comprise a wide spectrum of biomacromolecules synthesized in excess concentration by a wide variety of neoplastic cells. The markers could be endogenous products of highly active metabolic malignant cells or the products of newly switched on genes, which remained unexprssed in early life or newly acquired antigens at cellular and sub-cellular levels. The appearance of tumor marker and their concentration are related to the genesis and growth of malignant tumors in patients. An ideal tumor marker should be highly sensitive, specific, reliable with high prognostic value, organ specificity and it should correlate with tumor stages. However, none of the tumor markers reported to date has all these characteristics. Inspite of these limitations, many tumor markers have shown excellent clinical relevance in monitoring efficacy of different modes of therapies during entire course of illness in cancer patients. Additionally, determination of markers also helps in early detection of cancer recurrence and in prognostication.

Keywords: Cancer progression; Carcinogenesis; Malignancy; Prognostic Value; Tumor Markers.

PubMed Disclaimer

References

    1. Chu TM. Biochemical markers for human cancer, in Morphological Tumors Markers, general aspects and diagnostic relevance. Seifert G (ed.) Springer Verlag 1987; p: 19–42.
    1. Harnden DG. Human Tumor Markers: Biological Basis and Clinical Relevance. J Roy Soc Med. 1985;78:1071–2.
    1. Virji MA, Mercer DW, Herberman RB. Tumor Markers and their measurements. Pathol Res Pract. 1988;183:95–9. - PubMed
    1. Bates SE, Longo DL. Use of serum tumor markers in cancer diagnosis and management. Semin. Oncol. 1987;14:102–33. - PubMed
    1. Paterson AJ, Schlom J, Seares HF. A radioimmunoassay for the detection of a human tumor-associated glycoprotein (TAG 72) using monoclonal antibody B 72-3. Int J Cancer. 1986;37:659–66. doi: 10.1002/ijc.2910370504. - DOI - PubMed

LinkOut - more resources